UNSPSC 85812125: Introduction of other antineoplastic into ear, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into ear, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0B305

UNSPSC 85812125, Introduction of other antineoplastic into ear, percutaneous approach, is a Commodity code that does not align with substantive state and local procurement activity in the recent record. The code nominally describes a specialized medical procedure, but the opportunity sample tagged to this code spans telehealth platforms, nursing home operations, occupational health services, behavioral health programs, cancer registry, retinal screening devices, EMS staffing, employee wellness, and opioid treatment—none of which fit the code's stated scope. State and local buyers are not currently soliciting antineoplastic drug introductions through percutaneous ear approaches; the mismatch between code name and actual purchasing reflects either taxonomic misclassification or an obsolete coding assignment.

The recent opportunities in the block serve health plans, counties, cities, and state departments across California, Nevada, Georgia, Colorado, Florida, Texas, Kansas, and other states, but they cluster around behavioral health, occupational health, emergency medical services, and specialty clinical services rather than the specific oncologic procedure the code nominally describes. Pursuing this code as presently tagged carries little relevance for vendors in antineoplastic delivery, ear-focused therapeutics, or related specialties. Recommend confirming the correct UNSPSC classification before developing a pursuit strategy.